ADC: Great Place to Work

If sales carry on falling at 10% a quarter forget outsourcing, Abbott will close down the entire business within a year. BD did the same thing a few years back.

 

Get real. Are you blind AND stupid? Just what do you think they HAVE been doing with all these payoffs, zero R&D, and bare minimum marketing? They are IN THE PROCESS of shutting it down, RIGHT IN FRONT OF YOUR EYES because NO ONE WOULD BUY IT.

 

This is correct. Matters not a thing what sales are, flat, down, who cares. The decision has been made, the train has left the station, and every move ADC has made indicates that they are indeed winding this division down.

 

ADC has good strips and meters and what might be a very good new product. The division still makes money but less of it.

I think if MW could sell he could, but no one wants a strip company. But I don't think he will close it down yet. He will continue to cut costs (layoffs, etc) to keep the margins. If it stabilizes then hold and wait. Otherwise.....shutdown.

I used to work there and this is IMHO.

 

If you were here now, you would know there is no new product, just a dusted off dog. It will make no difference. The division is not making money to budget for ABT, not what the corp demands. This is unacceptable. ABT never recouped what it invested. Sales are declining, expenses cut to the none. There is no where else to go except cut the rest if it. The division is being dismantled piece by piece. It will not make until Q4. If you were still here you would know all that. You're lucky to be out. Why would you waste time coming here?

 

Wait for it ... (drum beat)... and here it is!

http://www.reuters.com/article/2014/07/11/us-mylan-abbott-exclusive-idUSKBN0FG2BT20140711

A European PL company to by the junk and off-patent drugs. ADC being the junk.

Now we know the source of all the mid-year rumors.

(You can all stop kissing Dunky's ass now)

 

Brilliant Move by Miles!! ABT is rocking!!! Abbott Laboratories is in advanced talks to sell its multibillion-dollar portfolio of generic drugs to Mylan Inc., according to a report from Reuters, citing people familiar with the matter.

 

Right. And if Miles was accused of sex with an under aged girl you would say that was also a "brilliant move".

 

Yes!!! This is a brilliant move to put ABT in a cash rich position! Getting rid of the older off-patent drugs and ADC is strategically correct. This also looks to position ABT move HQ and its incorporation off shore to lower corp tax rate country, and pivot away from the dying US healthcare system. This may be the deal the Obama administration made with ABT and other US based pharma companies to support the Affordable Care Act.

Miles is brilliant! Yes some sacrifices have to be made, like ADC, but it's the right thing for the shareholders.

 

Many powerful men have done just that in their old age, and it restores their vigor and vitality. Don't you want that so he can grow value for the shareholder?

 

Miles is gettin' old. He needs Viagra to "grow".

 

Maybe he should consult with Dunky. Maybe he can get some pointers from watching the way Dunky prances around like a old aging stud out to pasture at the sales meetings, desperately looking for any drunk and\or naive filly.

 

Doubters please read and say Amen!! Proud ABT/ADC Employees
Both Johnson & Johnson and Abbott Laboratories have long growth runways ahead. Johnson & Johnson has the lowest standard deviation of any business analyzed by Sure Dividend. The company's extremely low volatility is due to its diversification both within the health care industry and geographically, and because of the company's strong stable brands and status as the largest publicly traded healthcare business in the world.

Abbott Laboratories stands out due to its heavy exposure to emerging markets. The company generates more revenue from the developing world than the US. Over the next several years, Abbott will likely see over 50% of its revenue coming from quickly growing emerging markets.

The 8 Rules of Dividend Investing ranks Abbott Laboratories as a Top 10 stock due to its strong growth rate and low volatility. Johnson & Johnson ranks as the 28th highest stock gaining ground because of its extremely low volatility, which is partially offset by the company's relatively low revenue per share growth rate over the last 10 years.

 

Mindless and clueless cheerleader, read this:

http://www.reuters.com/article/2014/...0FG2BT20140711

Abbot is taking out the trash, including ADC. Hope you have a lot of stock. You're gonna have too cash that in to live off when your OI runs out.

 

Not sure. Please explain.